Jump Financial LLC Takes $687,000 Position in Quanterix Corporation $QTRX

Key Points

• Jump Financial LLC acquired 105,457 shares of Quanterix Corporation, valued at approximately $687,000, representing a 0.27% ownership stake in the company as of its latest SEC filing.
• Several institutional investors, including Hsbc Holdings PLC and Quantbot Technologies LP, significantly increased their positions in Quanterix during the first quarter, reflecting growing interest in the stock.
• Quanterix recently reported a quarterly earnings loss that missed expectations, with an EPS of ($0.47), and the stock currently maintains a consensus rating of "Hold" with a price target suggested at $11.75.

Jump Financial LLC purchased a new stake in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 105,457 shares of the company's stock, valued at approximately $687,000. Jump Financial LLC owned 0.27% of Quanterix as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Invesco Ltd. lifted its position in shares of Quanterix by 16.3% in the 4th quarter. Invesco Ltd. now owns 33,654 shares of the company's stock worth $358,000 after purchasing an additional 4,729 shares during the period. Raymond James Financial Inc. bought a new stake in Quanterix during the 4th quarter valued at about $570,000. Dimensional Fund Advisors LP lifted its stake in shares of Quanterix by 0.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 893,645 shares of the company's stock worth $9,500,000 after buying an additional 6,099 shares in the last quarter. MetLife Investment Management LLC grew its holdings in shares of Quanterix by 21.9% during the fourth quarter. MetLife Investment Management LLC now owns 23,983 shares of the company's stock valued at $255,000 after buying an additional 4,303 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Quanterix by 219.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,702 shares of the company's stock valued at $61,000 after acquiring an additional 3,915 shares in the last quarter. 86.48% of the stock is owned by institutional investors.

Insider Activity at Quanterix

In other Quanterix news, Director David R. Walt acquired 123,990 shares of the stock in a transaction dated Friday, June 13th. The stock was purchased at an average price of $6.14 per share, with a total value of $761,298.60. Following the transaction, the director directly owned 1,866,933 shares of the company's stock, valued at $11,462,968.62. This trade represents a 7.11% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William P. Donnelly purchased 93,113 shares of the company's stock in a transaction dated Friday, June 6th. The shares were acquired at an average price of $5.44 per share, for a total transaction of $506,534.72. Following the purchase, the director directly owned 139,094 shares of the company's stock, valued at approximately $756,671.36. The trade was a 202.50% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 463,113 shares of company stock valued at $2,625,444. 6.80% of the stock is owned by insiders.

Quanterix Trading Down 0.2%

Shares of NASDAQ QTRX traded down $0.01 during midday trading on Thursday, hitting $4.34. The company's stock had a trading volume of 188,812 shares, compared to its average volume of 778,073. Quanterix Corporation has a 12-month low of $4.05 and a 12-month high of $15.85. The firm has a market cap of $201.68 million, a P/E ratio of -2.39 and a beta of 1.03. The business's 50 day moving average is $5.52 and its two-hundred day moving average is $5.91.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.06). Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. The company had revenue of $24.48 million for the quarter, compared to the consensus estimate of $29.73 million. Quanterix has set its FY 2025 guidance at EPS. On average, analysts predict that Quanterix Corporation will post -0.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on QTRX shares. Wall Street Zen cut Quanterix from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Canaccord Genuity Group restated a "hold" rating and issued a $5.00 price objective (down from $12.00) on shares of Quanterix in a research report on Monday, August 11th. One equities research analyst has rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Quanterix presently has a consensus rating of "Hold" and a consensus price target of $11.75.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.